We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PBA:NYSEPembina Pipeline Corp. Analysis

Data as of 2026-05-23 - not real-time

$49.58

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Pembina Pipeline is trading at $49.58, comfortably above its 20‑day ($46.96) and 50‑day ($45.30) moving averages and near the $50.10 resistance level. The stock shows bullish momentum with a bullish MACD crossover, but the RSI of 75 signals an overbought condition, and the Fear & Greed Index is at an "Extreme Greed" 91.6, suggesting heightened market optimism. Recent earnings releases highlighted a stronger‑than‑expected first‑quarter adjusted EBITDA and an upward revision of full‑year guidance, which helped lift sentiment, yet Citi downgraded the stock to neutral, citing valuation concerns.
Fundamentally, the market price is far above the DCF‑derived fair value of $7.74 and the analyst median target of $41.74, implying a substantial overvaluation. The company carries a high debt‑to‑equity ratio of 82% and a dividend payout ratio exceeding 100%, raising questions about dividend sustainability despite a 4.19% yield. With a 30‑day volatility of ~20%, a low beta, and solid operating margins, the risk profile is mixed, prompting a cautious stance on the stock's near‑term upside while recognizing its long‑term cash‑flow stability.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI in overbought territory
  • Price approaching resistance with limited upside
  • High valuation relative to DCF and analyst target

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Persistent overvaluation despite solid cash flow
  • Dividend payout above 100% and high leverage
  • Potential price correction toward target price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Stable midstream contract revenues
  • Share repurchase program and potential debt reduction
  • Attractive yield if dividend becomes sustainable at lower price

Key Metrics & Analysis

Financial Health

Revenue Growth-7.70%
Profit Margin22.23%
P/E Ratio25.7
ROE9.81%
ROA4.28%
Debt/Equity82.35
P/B Ratio2.6
Op. Cash Flow$2.8B
Free Cash Flow$1.4B
Industry P/E21.6

Technical Analysis

TrendBullish
RSI75.0
Support$43.27
Resistance$50.10
MA 20$46.96
MA 50$45.30
MA 200$40.91
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$7.74
Target Price$41.74
Upside/Downside-15.82%
GradeOvervalued
TypeBlend
Dividend Yield4.19%

Risk Assessment

Beta-0.07
Volatility20.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.